Five Star Bancorp
F:4F6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Five Star Bancorp
F:4F6
|
US |
|
Estia Health Ltd
F:26E
|
AU |
|
U
|
United Therapeutics Corp
XBER:UTH
|
US |
|
B
|
Becton Dickinson and Co
XBER:BOX
|
US |
|
C
|
CureVac NV
XBER:5CV
|
DE |
Wall St Price Targets
4F6 Price Targets Summary
Five Star Bancorp
According to Wall Street analysts, the average 1-year price target for 4F6 is 35.9 EUR with a low forecast of 33.38 EUR and a high forecast of 39.04 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4F6's stock price target?
Price Target
35.9
EUR
According to Wall Street analysts, the average 1-year price target for 4F6 is 35.9 EUR with a low forecast of 33.38 EUR and a high forecast of 39.04 EUR.
What is the Revenue forecast for Five Star Bancorp?
Projected CAGR
19%
Over the last 5 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 2 years is 19%.
What is the Net Income forecast for Five Star Bancorp?
Projected CAGR
18%
Over the last 5 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 2 years is 18%.
